This paper concerns with a multi-echelon inventory/distribution system considering one-warehouse and N-retailers. The retailers are replenished from the warehouse. We assume that the demand rate at each retailer is known. The problem consists of determining the optimal reorder policy which minimizes the overall cost, that is, the sum of the holding and replenishment costs. Shortages are not allowed and lead times are negligible. We study two situations: when the retailers make decisions independently and when the retailers are branches of the same firm. Solution methods to determine near-optimal policies in both cases are provided. Computational results on several randomly generated problems are reported.
Tuberculosis (TB) remains a worldwide problem. Despite the high disease rate, not all who are infected with Mycobacterium Tuberculosis (Mtb) develop disease. Interferon-γ (IFN-γ) specific T cell immune assays such as Quantiferon and Elispot, as well as a skin hypersensitivity test, known as a tuberculin skin test, are widely used to infer infection. These assays measure immune conversion in response to Mtb. Some individuals measure persistently negative to immune conversion, despite high and prolonged exposure to Mtb. Increasing interest into this phenotype has led to multiple publications describing various aspects of these responses. However, there is a lack of a unified “resister” definition. A universal definition will improve cross study data comparisons and assist with future study design and planning. We review the current literature describing this phenotype and make recommendations for future studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.